Machine Learning

Industry leaders at the GenScript Global Forum agree: the era of AI experimentation is over. Now, the hard work of scaling and building trust begins.

As T+1 deadlines squeeze financial firms, STP Investment Services unveils SmartSettle AI to predict and prevent costly settlement failures.

NewcelX sharpens its focus on a Type 1 Diabetes cell therapy, but faces a competitive landscape and significant financial hurdles in its ambitious quest.

A team with a history of building billion-dollar companies just raised $3.9M to bring AI to the chaotic $600B electronics procurement industry.

PSI's Gov Secure Cloud achieves a key federal security milestone, paving a faster path for agencies to adopt modern, secure testing and assessment solutions.

A German biotech's novel oral drug for herpes is moving to Phase 2 trials, offering new hope against a widespread and often resistant virus.

A new center in China is using a novel drug and special policies to offer hope against NUT carcinoma, a rare and deadly cancer affecting the young.

With new teams in four countries, IndySoft expands its reach to meet rising demand for advanced, measurement-driven industrial asset management.

New platform ends 'slow data' for category teams, linking shelf space directly to sales performance with real-time, unified insights from a single source.

The FDA has qualified MolecuLightDX's measurement tool, a move set to standardize clinical trials, accelerate innovation, and redefine wound healing.

Datawizz launched Continuous Learning, a new tool to bridge the gap between AI training and production, promising to make models smarter with every use.

Philips launches the Evnia 27M2N5500XD, a monitor with a 1000Hz mode. We dive into the tech, the competition, and what it means for esports.

ENA Respiratory's INNA-051 nasal spray, a virus-agnostic shield, has begun Phase II trials, offering new hope for high-risk communities.

With new board members from J&J MedTech and key VCs, the firm is set to scale its real-time AI-powered tissue imaging platform for cancer diagnostics.

Stockholm's Munters Group reports a massive 191% surge in Q4 orders fueled by AI's cooling needs, yet faces a profit squeeze from tariffs and costs.

A new report reveals how global instability and AI's energy thirst are turning blue-chip stocks into unpredictable assets, reshaping investment for 2026.

GigCapital9's successful $253 million IPO signals a SPAC market rebound, setting its sights on cybersecurity, AI, and quantum computing innovators.

OnePay's new free, in-app tax service challenges TurboTax and H&R Block, signaling a major shift toward all-in-one financial management platforms.

As Personalis heads to a key investor conference, its groundbreaking cancer tech faces off against questions of revenue volatility and profitability.

A new batch pricing tool for FICO Score 10T lets lenders compare credit models at scale, promising greater efficiency and precision in mortgage lending.